| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |